{
  "id": "5c897555d558e5f232000009",
  "type": "factoid",
  "question": "Which was the first adeno-associated virus vector gene therapy product approved in the United States?",
  "ideal_answer": "The first adeno-associated virus vector gene therapy product in the United States was Luxturna.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30089698"
  ],
  "snippets": [
    {
      "text": "Gene therapy utilizing viral vectors has experienced recent success, culminating in U.S. Food and Drug Administration approval of the first adeno-associated virus vector gene therapy product in the United States: Luxturna for inherited retinal dystrophy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30089698",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Luxturna"
}